London, United Kingdom

Sanjay Jain

USPTO Granted Patents = 44 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
44 patents (USPTO):

Title: Innovator Spotlight: Sanjay Jain - Pioneering Advances in Glycopolysialylation and Polysaccharide Fractionation

Introduction

Sanjay Jain, a distinguished inventor based in London, United Kingdom, has made significant contributions to the fields of glycopolysialylation and polysaccharide fractionation. With a remarkable portfolio of 44 patents, his innovative work has propelled advancements in medical therapeutics and drug delivery systems.

Latest Patents

Jain's latest patents showcase his expertise in the precise conjugation of water-soluble polymers to non-blood coagulation proteins. One of his groundbreaking inventions involves the utilization of polysialic acid (PSA) or modified PSA (mPSA) to attach to oxidized carbohydrate moieties, resulting in novel conjugates with diverse applications in drug delivery. Additionally, his work on the fractionation of charged polysaccharides has led to the development of purified, low polydispersity fractions that are ideal for the production of PSA-derivatized therapeutic agents.

Career Highlights

Throughout his career, Sanjay Jain has held key positions at prominent companies such as Lipoxen Technologies Incorporated and Baxalta GmbH. His tenure at these organizations has provided him with invaluable industry insights and resources to drive his innovative research forward. Jain's expertise in bioconjugation and polysaccharide chemistry has positioned him as a leader in the development of novel pharmaceutical interventions.

Collaborations

Collaboration plays a pivotal role in Jain's inventive process, with notable coworkers including Peter Laing and Gregory Gregoriadis. These partnerships have fostered a dynamic environment for exchanging ideas, leveraging expertise, and pushing the boundaries of scientific innovation. By working together, Jain and his collaborators have been able to achieve groundbreaking results in the realm of biopharmaceuticals.

Conclusion

In conclusion, Sanjay Jain's prolific career as an inventor is marked by a relentless pursuit of excellence and a commitment to pioneering advancements in glycopolysialylation and polysaccharide fractionation. His innovative patents and collaborations underscore his status as a trailblazer in the field of medical biotechnology, with a lasting impact on the landscape of drug development and therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…